We are live on
!
Find out more
Cambridge Investment Research Advisors Portfolio holdings
AUM
$44.6B
1-Year Est. Return
28.94%
This Fund
S&P 500
This Quarter
Est. Return
+2.04%
1 Year Est. Return
+28.94%
3 Year Est. Return
+82.62%
5 Year Est. Return
+90.41%
10 Year Est. Return
+281.48%
AUM
$4.42B
AUM Growth
+$200M
(+4.7%)
Cap. Flow
+$138M
Cap. Flow
% of AUM
3.13%
Top 10 Holdings %
Top 10 Hldgs %
20.05%
Holding
1,701
New
123
Increased
762
Reduced
644
Closed
96
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
DPLO
DIPLOMAT PHARMACY, INC.
DPLO
|
+$34.6M |
| 2 |
iShares MSCI USA Min Vol Factor ETF
USMV
|
+$24.7M |
| 3 |
Schwab US Aggregate Bond ETF
SCHZ
|
+$22.5M |
| 4 |
iShares 7-10 Year Treasury Bond ETF
IEF
|
+$15.7M |
| 5 |
SPDR Gold Trust
GLD
|
+$14.4M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
State Street SPDR S&P 500 ETF Trust
SPY
|
+$20.4M |
| 2 |
Vanguard Morningstar Total Stock Market ETF
VTI
|
+$15.2M |
| 3 |
State Street Consumer Discretionary Select Sector SPDR ETF
XLY
|
+$10.9M |
| 4 |
iShares Core S&P 500 ETF
IVV
|
+$10.6M |
| 5 |
State Street DoubleLine Total Return Tactical ETF
TOTL
|
+$10.3M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Financials | 4.64% |
| 2 | Technology | 4.52% |
| 3 | Healthcare | 4.42% |
| 4 | Consumer Staples | 4.24% |
| 5 | Industrials | 3.99% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
1
Vanguard S&P 500 ETF
VOO
$979B
| $192M | 4.34% |
1,018,904
-28,800
| -3% | -$5.15M |
|
2
Vanguard Total International Stock ETF
VXUS
$155B
| $134M | 3.02% |
2,978,992
+292,105
| +11% | +$12.5M |
|
|
3
iShares Core S&P 500 ETF
IVV
$878B
| $102M | 2.3% |
491,928
-53,936
| -10% | -$10.6M |
|
4
Apple
AAPL
$4.54T
| $88.5M | 2% |
3,247,896
+210,692
| +7% | +$5.25M |
|
5
Vanguard Total Bond Market
BND
$157B
| $72.1M | 1.63% |
870,936
-63,603
| -7% | -$5.2M |
|
6
Vanguard FTSE Emerging Markets ETF
VWO
$121B
| $65.4M | 1.48% |
1,891,585
+130,753
| +7% | +$4.1M |
|
7
Vanguard Total International Bond ETF
BNDX
$81.9B
| $64.5M | 1.46% |
1,182,038
+112,185
| +10% | +$6.03M |
|
8
Vanguard Short-Term Bond ETF
BSV
$44.7B
| $59M | 1.33% |
731,538
+54,326
| +8% | +$4.35M |
|
|
9
State Street SPDR S&P 500 ETF Trust
SPY
$790B
| $57.4M | 1.3% |
279,253
-104,401
| -27% | -$20.4M |
|
|
10
iShares MSCI USA Min Vol Factor ETF
USMV
$23.5B
| $52.3M | 1.18% |
1,191,613
+594,546
| +100% | +$24.7M |
|
11
ExxonMobil
XOM
$644B
| $52M | 1.17% |
621,602
+3,070
| +0.5% | +$246K |
|
|
DPLO
12
DELISTED
DIPLOMAT PHARMACY, INC.
DPLO
| $46.6M | 1.05% |
1,700,656
+1,175,784
| +224% | +$34.6M |
|
13
Vanguard FTSE Developed Markets ETF
VEA
$229B
| $45.9M | 1.04% |
1,278,808
+8,395
| +0.7% | +$290K |
|
|
14
Vanguard Morningstar Total Stock Market ETF
VTI
$660B
| $43.5M | 0.98% |
415,134
-153,618
| -27% | -$15.2M |
|
15
GE Aerospace
GE
$374B
| $42.9M | 0.97% |
281,395
-517
| -0.2% | -$73K |
|
16
Vanguard Extended Market ETF
VXF
$30.3B
| $42M | 0.95% |
507,792
+4,561
| +0.9% | +$353K |
|
17
iShares Preferred and Income Securities ETF
PFF
$13.3B
| $36.8M | 0.83% |
942,419
+313,047
| +50% | +$12M |
|
18
iShares 0-1 Year Treasury Bond ETF
SHV
$20.8B
| $36.1M | 0.82% |
326,981
+67,183
| +26% | +$7.41M |
|
19
AT&T
T
$159B
| $35M | 0.79% |
1,181,681
+47,641
| +4% | +$1.32M |
|
20
iShares Russell 2000 ETF
IWM
$79.8B
| $33.2M | 0.75% |
300,370
+61,607
| +26% | +$6.38M |
|
|
21
State Street DoubleLine Total Return Tactical ETF
TOTL
$4.09B
| $33.1M | 0.75% |
669,757
-209,409
| -24% | -$10.3M |
|
22
Berkshire Hathaway Class B
BRK.B
$1.1T
| $32.9M | 0.74% |
231,826
+5,975
| +3% | +$792K |
|
23
Invesco QQQ Trust
QQQ
$453B
| $31.3M | 0.71% |
286,514
-79,077
| -22% | -$8.21M |
|
24
Vanguard Intermediate-Term Bond ETF
BIV
$28.8B
| $31.1M | 0.7% |
359,939
+67,086
| +23% | +$5.69M |
|
25
Johnson & Johnson
JNJ
$618B
| $30M | 0.68% |
277,293
+7,674
| +3% | +$794K |
|
Similar funds
AS
LP
Cambridge Investment Research Advisors's Q1 2016 Portfolio in Review
As of Q1 2016, Cambridge Investment Research Advisors held 1,701 positions worth $4.42B, up 4.7% from $4.22B the previous quarter. Its ten largest holdings account for 20% of the portfolio.
Cambridge Investment Research Advisors deployed $138M of net new capital in Q1 2016, opening 123 new positions and adding to 762 existing holdings. Its largest new stake was Vanguard Long-Term Treasury ETF: 35,170 shares worth $2.83M.
By sector, the portfolio is most concentrated in Financials at 4.6% of assets, down from 4.9% a quarter earlier, followed by Technology and Healthcare.
On the sell side, the largest reduction was State Street SPDR S&P 500 ETF Trust, an estimated $20.4M trimmed.
- Cambridge Investment Research Advisors's largest Q1 2016 buy was Vanguard Long-Term Treasury ETF: 35,170 shares worth $2.83M.
- Cambridge Investment Research Advisors added most to DIPLOMAT PHARMACY, INC. in Q1 2016, an estimated $34.6M increase.
- Cambridge Investment Research Advisors's biggest Q1 2016 reduction was State Street SPDR S&P 500 ETF Trust, cutting an estimated $20.4M.
- Cambridge Investment Research Advisors fully exited iShares Currency Hedged MSCI Emerging Markets in Q1 2016, selling an estimated $1.72M.
- Cambridge Investment Research Advisors's ten largest holdings make up 20% of its $4.42B portfolio in Q1 2016.
- Cambridge Investment Research Advisors opened 123 new positions and closed 96 in Q1 2016.
- Cambridge Investment Research Advisors's portfolio value rose 4.7% quarter-over-quarter to $4.42B.
Based on Cambridge Investment Research Advisors's 13F filing for Q1 2016, filed 3 May 2016.